Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: A multi-class pattern recognition approach
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The stimulant drug methylphenidate (MPH) and the non-stimulant drug atomoxetine (ATX) are both widely used for the treatment of attention deficit/hyperactivity disorder (ADHD), but their differential effects on human brain function are poorly understood. PET and blood oxygen level dependent (BOLD) fMRI have been used to study the effects of MPH and BOLD fMRI is beginning to be used to delineate the effects of MPH and ATX in the context of cognitive tasks. The BOLD signal is a proxy for neuronal activity and is dependent on three physiological parameters: regional cerebral blood flow (rCBF), cerebral metabolic rate of oxygen and cerebral blood volume. To identify areas sensitive to MPH and ATX and assist interpretation of BOLD studies in healthy volunteers and ADHD patients, it is therefore of interest to characterize the effects of these drugs on rCBF. In this study, we used arterial spin labeling (ASL) MRI to measure rCBF non-invasively in healthy volunteers after administration of MPH, ATX or placebo. We employed multi-class pattern recognition (PR) to discriminate the neuronal effects of the drugs, which accurately discriminated all drug conditions from one another and provided activity patterns that precisely localized discriminating brain regions. We showed common and differential effects in cortical and subcortical brain regions. The clearest differential effects were observed in four regions: (i) in the caudate body where MPH but not ATX increased rCBF, (ii) in the midbrain/substantia nigra and (iii) thalamus where MPH increased and ATX decreased rCBF plus (iv) a large region of cerebellar cortex where ATX increased rCBF relative to MPH. Our results demonstrate that combining ASL and PR yields a sensitive method for detecting the effects of these drugs and provides insights into the regional distribution of brain networks potentially modulated by these compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Vaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., & Gabrieli, J. D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14494 · Cited by 845 · cited 2×
“…to investigate the effects of MPH and ATX on brain activation during cognitive tasks in healthy volunteers (e.g. Chamberlain et al., 2009; Dodds et al., 2008; Graf et al., 2011; Marquand et al., 2011) and patients with ADHD (e.g. Rubia et al., 2011; Schweitzer et al., 2004; Vaidya et al., 1998).”
BackgroundMethodMorón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681
Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666
Mehta, M. A., Owen, A. M., Sahakian, B. J., Mavaddat, N., Pickard, J. D., & Robbins, T. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-j0004.2000 · Cited by 608 · cited 9×
“…study the effects of MPH and ATX on task networks associated with response inhibition (Chamberlain et al., 2009; Vaidya et al., 1998), error monitoring (Graf et al., 2011; Rubia et al., 2011), reversal learning (Dodds et al., 2008) and working memory (Mehta et al., 2000; Schweitzer et al., 2004).”
BackgroundInfluentialSelf-citationImaging endogenous dopamine competition with [11C]raclopride in the human brain
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., et al. (1994) · Synapse · doi:10.1002/syn.890160402 · Cited by 379 · cited 1×
“…in the caudate body, congruent with multiple lines of evidence showing that MPH increases striatal DA concentrations (e.g. Bymaster et al., 2002; Volkow et al., 1994), although the striatum was not observed following methylphenidate challenge in human H2[O15] PET studies (Mehta et al., 2000;…”
BackgroundNewcorn, J. H., Kratochvil, C. J., Allen, A. J., Casat, C. D., Ruff, D. D., Moore, R. J., Michelson, D., & Atomoxetine/Methylphenidate Comparative Study Group (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05091676 · Cited by 336 · cited 3×
“…importantly, ATX provides an alternative treatment for patients who do not ging, Centre for Neuroimaging ny Park, London, SE58AF, UK. rquand). license. respond to stimulants, it has a reduced abuse liability and a reduced risk of motor side effects (Biederman et al., 2004; Newcorn et al., 2008).”
BackgroundEvidence-based pharmacotherapy for attention-deficit hyperactivity disorder
Biederman, J., Spencer, T., & Wilens, T. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003973 · Cited by 253 · cited 2×
“…importantly, ATX provides an alternative treatment for patients who do not ging, Centre for Neuroimaging ny Park, London, SE58AF, UK. rquand). license. respond to stimulants, it has a reduced abuse liability and a reduced risk of motor side effects (Biederman et al., 2004; Newcorn et al., 2008).”
BackgroundAnti-hyperactivity medication: methylphenidate and amphetamine
Seeman, P., & Madras, B. K. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000421 · Cited by 252
Hannestad, J., Gallezot, J.-D., Planeta-Wilson, B., Lin, S.-F., Williams, W. A., van Dyck, C. H., Malison, R. T., Carson, R. E., & Ding, Y.-S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.017 · Cited by 236
Rubia, K., Halari, R., Cubillo, A., Smith, A. B., Mohammad, A.-M., Brammer, M., & Taylor, E. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.30 · Cited by 184
Schweitzer, J. B., Lee, D. O., Hanford, R. B., Zink, C. F., Ely, T. D., Tagamets, M. A., Hoffman, J. M., Grafton, S. T., & Kilts, C. D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.011 · Cited by 135
Dodds, C. M., Muller, U., Clark, L., van Loon, A., Cools, R., & Robbins, T. W. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1153-08.2008 · Cited by 113 · cited 4×
“Further, and as noted above, the BOLD signal depends on rCMRO2 and rCBV in addition to rCBF, which complicates the interpretation of studies that have employed BOLD fMRI to investigate the effects of MPH and ATX on brain activation during cognitive tasks in healthy volunteers (e.g. Chamberlain et al., 2009; Dodds et a…”
BackgroundInfluentialFaraone, S. V., Biederman, J., Spencer, T., Michelson, D., Adler, L., Reimherr, F., & Glatt, S. J. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-16 · Cited by 108
Kemner, J. E., Starr, H. L., Ciccone, P. E., Hooper-Wood, C. G., & Crockett, R. S. (2005) · Advances in Therapy · doi:10.1007/bf02849870 · Cited by 99 · cited 1×
“MPH has a greater clinical efficacy than ATX (Faraone et al., 2005; Kemner et al., 2005; Michelson et al., 2001; Newcorn et al., 2008; Spencer et al., 1998; Starr and Kemner, 2005), but ATX offers several advantages over MPH.”
BackgroundGilbert, D. L., Ridel, K. R., Sallee, F. R., Zhang, J., Lipps, T. D., & Wassermann, E. M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300806 · Cited by 97
Cited by
A Review of Feature Reduction Techniques in Neuroimaging
Mwangi, B., Tian, T. S., & Soares, J. C. (2014) · Neuroinformatics · doi:10.1007/s12021-013-9204-3 · Cited by 559
The search for imaging biomarkers in psychiatric disorders
Abi-Dargham, A., & Horga, G. (2016) · Nature Medicine · doi:10.1038/nm.4190 · Cited by 311
Paloyelis, Y., Doyle, O. M., Zelaya, F. O., Maltezos, S., Williams, S. C., Fotopoulou, A., & Howard, M. A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.005 · Cited by 187
The Cognition-Enhancing Effects of Psychostimulants Involve Direct Action in the Prefrontal Cortex
Spencer, R. C., Devilbiss, D. M., & Berridge, C. W. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.09.013 · Cited by 164
“However, additional evidence indicates that clinically-relevant doses of psychostimulants exert a more complex pattern of actions on frontostriatal activity that are task, region, and hemisphere-dependent (13,71-74).”
Bhaumik, R., Jenkins, L. M., Gowins, J. R., Jacobs, R. H., Barba, A., Bhaumik, D. K., & Langenecker, S. A. (2017) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.02.018 · Cited by 72
“…(IPC, Hamilton et al., 2012), amygdala (Siegle et al., 2007), anterior insula, dorsal ACC (Strigo et al., 2008; Briceño et al., 2013), pregenual ACC (Horn et al., 2010), DLPFC (Bench et al., 1992;Mayberg et al., 1999; Jacobs et al., 2014), and hippocampus (Cao et al., 2012; Sambataro et al., 2013).”
BackgroundResult
Metadata
- Authors
- Marquand, A. F., O'Daly, O. G., De Simoni, S., Alsop, D. C., Maguire, R. P., Williams, S. C. R., Zelaya, F. O., & Mehta, M. A.
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 60
- Issue
- 2
- Pages
- 1015-1024
- ISSN
- 1053-8119 (ISSN-L)
- OpenAlex
- W1979289529
- Cited by
- 72
- References
- 16
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.